Monitoring for adverse pregnancy outcomes related to drug exposure during pregnancy.
Andrews
E
E
Tennis
P
P
D000212:Acyclovir / Q000009:adverse effects; D016022:Case-Control Studies; D005260:Female; D005500:Follow-Up Studies; D006558:Herpes Genitalis; D006801:Humans; D011247:Pregnancy; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects; D011358:Product Surveillance, Postmarketing; D012042:Registries
D000212:Acyclovir